D.A. Vorobiof
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Breast Cancer Treatment Studies 3
- Oncology 4
- Inflammatory Biomarkers in Disease Prognosis 1
- Cancer Treatment and Pharmacology 1
- Cancer Immunotherapy and Biomarkers 1
- Cancer Diagnosis and Treatment 1
- Co-authors
- Mitch Dowsett (1 shared paper)Ulrich Richard Kleeberg (1 shared paper)Martin Robert Chasen (1 shared paper)David John Dodwell (1 shared paper)John F.R. Robertson (1 shared paper)Bernardo Leon Rapoport (2 shared papers)Graham Lawrence Cohen (1 shared paper)Teresa Smit (1 shared paper)
- Journals
- Annals of Oncology (5 papers)European Journal of Cancer (1 paper)International Journal of Gynecological Cancer (1 paper)Carolina Digital Repository (University of North Carolina at Chapel Hill) (1 paper)
- Partner nations
- United KingdomSouth AfricaIsrael
In The Last Decade
D.A. Vorobiof
8 papers receiving 2.0k citations
D.A. Vorobiof's Hit Papers
Peers
Comparison fields: 5 of 73
- Oncology 923
- Cancer Research 467
- Pulmonary and Respiratory Medicine 868
- Genetics 96
- Radiology, Nuclear Medicine and Imaging 129
Countries citing papers authored by D.A. Vorobiof
This map shows the geographic impact of D.A. Vorobiof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.A. Vorobiof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.A. Vorobiof more than expected).
Fields of papers citing papers by D.A. Vorobiof
This network shows the impact of papers produced by D.A. Vorobiof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.A. Vorobiof. The network helps show where D.A. Vorobiof may publish in the future.
Co-authors
The 10 scholars most cited alongside D.A. Vorobiof, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) Hit paper breakdown → | 2020 | 1014 |
| 2 | 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) Hit paper breakdown → | 2018 | 870 |
| 3 | 2021 | 116 | |
| 4 | 1996 | 4 | |
| 5 | 2003 | 3 | |
| 6 | 2019 | 2 | |
| 7 | 2020 | 1 | |
| 8 | 2021 | 1 |
About D.A. Vorobiof
D.A. Vorobiof is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Economics and Econometrics and Reproductive Medicine, having authored 8 papers that have together received 2.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Advanced Breast Cancer Therapies (3 papers), Economic and Financial Impacts of Cancer (2 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Cancer Treatment and Pharmacology (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (923 citations), Cancer Research (467 citations), Pulmonary and Respiratory Medicine (868 citations), Genetics (96 citations) and Radiology, Nuclear Medicine and Imaging (129 citations). D.A. Vorobiof has collaborated with scholars based in United Kingdom, South Africa and Israel. Frequent co-authors include Mitch Dowsett, Ulrich Richard Kleeberg, Martin Robert Chasen, David John Dodwell, John F.R. Robertson, Bernardo Leon Rapoport, Graham Lawrence Cohen, Teresa Smit, Andrey Litvin and Einav Sapir. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, International Journal of Gynecological Cancer and Carolina Digital Repository (University of North Carolina at Chapel Hill).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.